Filing Details

Accession Number:
0001179110-19-009165
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-05 20:11:39
Reporting Period:
2019-08-03
Accepted Time:
2019-08-05 20:11:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1159036 Halozyme Therapeutics Inc. HALO Biological Products, (No Disgnostic Substances) (2836) 880488686
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1739693 Dimitrios Chondros C/O Halozyme Therapeutics, Inc.
11388 Sorrento Valley Road
San Diego CA 92121
Svp, Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-08-03 1,328 $16.70 38,584 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The reported disposition of 1,328 shares represents the shares that were sold by the reporting person to cover minimum statutory obligations due upon vesting of 3,750 restricted stock award shares.